EYETECHCARE

EYE TECH CARE is a Lyon-based startup founded in 2006 by therapeutic ultrasound experts. The company specializes in developing and marketing non-invasive medical devices for eye disease treatment. Its flagship product, the EyeOP1, is a groundbreaking therapeutic device designed to address uncontrolled glaucoma, a condition affecting over 120 million individuals globally. Despite its widespread prevalence, glaucoma and ocular hypertension are often undiagnosed, contributing to their status as the second leading cause of blindness as per the World Health Organization. EYE TECH CARE's innovative approach to treatment has garnered the support of prominent scientific and financial partners. In January 2016, the company secured a significant €25.00M Series D investment from Everpine Capital, underscoring the growing recognition and support for the company's pioneering work in the Health Care sector.